InstaCare Corp. in Contract Deliberations With Mexican Government Health Institute ISSSTE for E-Health Implementation Pact

Company to Implement Proprietary MD@Hand Technologies in Broad

Pharmaceutical and Diagnostics Initiative Targeted to 11+ Million Lives

Jul 20, 2006, 01:00 ET from InstaCare Corp.

    NEW YORK, July 20 /PRNewswire-FirstCall/ -- InstaCare Corp. (OTC
 Bulletin Board: ISCR), a leading distributor of life saving prescription
 drugs and diagnostics and Wi-Fi PDA technology provider to the medical,
 lodging and satellite media industries and the developer of patent-pending
 technologies for e-health and EMR applications today announced that it has
 entered negotiations for an exclusive Strategic Development and Marketing
 Agreement with the health agency ISSSTE (Instituto de Seguridad y Servicios
 Sociales de los Trabajadores del Estado) an administrative arm of the
 Mexican Federal government. This initiative will cover the company's
 proprietary e-health technologies tied to its prescription drug
 prescription fulfillment systems.
     The focus of the proposed agreement will provide the company's MD@Hand
 Wi-Fi PDA-based e-health products to the fast growing Mexican physician
 base that services the 11 million eligible patients covered by the services
 of ISSSTE. The parties also plan a near term joint strategic endeavor with
 the workers guild IMSS to open a closed door pharmacy to offer prescription
 drugs and our current diabetic testing products to IMSS members. Currently
 these members account for 10 million prescriptions per month.
     Robert Cox, Chairman and CEO of InstaCare Corp. commented, "InstaCare's
 e-health technologies remain the industry's Wi-Fi standard-bearer. The
 execution of an agreement with ISSSTE will mark the largest implementation
 of e-health technology to date and their accelerated market penetration and
     The company believes this e-health initiative should help invigorate
 the U.S. market for e-health technologies. The company also anticipates
 that discussions with the workers guild IMSS will conclude quickly so that
 we may provide guild members with InstaCare's highly profitable
 prescription fulfillment programs.
     Mr. Cox concluded, "Since we began our prescription drug distribution
 strategy, our technology fulfillment products have justifiably consumed an
 ever-increasing proportion of the Company's available resources. The rapid
 embrace by the Mexican health institute has compelled an escalating and
 pragmatic modification in our strategic and operational focus. Our roots,
 however, emanate from the healthcare segment of the greater technology
 industry. Agreements such as the one we are pursuing to completion in
 Mexico will facilitate our rapidly evolving organization and allow us
 fulfill the promise and expectations we believe are in front of us."
     For more information, visit the InstaCare Web Site: or contact Carla Hintz, the Wells Group (480)
     For those interested in a more detailed analysis of InstaCare Corp.,
 its business and prospects, please visit and type
 in the access code ACE to receive copies of several recent independent
 research reports published by Wasserman-Morris detailing InstaCare.
     Safe Harbor Statement from InstaCare Corp: This press release contains
 forward-looking statements that involve a number of risks and
 uncertainties. Important factors that could cause actual results to differ
 materially from those indicated by such forward-looking statements include,
 but are not limited to, economic conditions affecting retailers; continuing
 success introducing new products; the Company's ability to finance its
 planned expansion efforts; and changes in regulations affecting the
 Company's core business. We do not intend to update any of the
 forward-looking statements after the date of this document to conform these
 statements to actual results or to changes in our expectations, except as
 required by law

SOURCE InstaCare Corp.